28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 261 / 薬物数 : 276 - (DrugBank : 81) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 178

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00052884 (ClinicalTrials.gov)	October 2003	24/1/2003	Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing P ...	A Phase I Study of Amifostine Followed by High-Dose Escalation of Melphalan With Stem Cell Reconstit ...	Drug/Agent Toxicity by Tissue/Organ;Multiple Myeloma and Plasma Cell Neoplasm	Biological: filgrastim;Drug: amifostine trihydrate;Drug: melphalan;Procedure: bone marrow ablation wi ...	Eastern Cooperative Oncology Group	National Cancer Institute (NCI)	Terminated	18 Years	70 Years	Both	8	Phase 1	United States
2	NCT00007995 (ClinicalTrials.gov)	July 1999	6/1/2001	Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or ...	Phase 2 Study Of High Dose Chemotherapy Followed By Autologous Hematopoietic Stem Cell Support In Pa ...	Multiple Myeloma and Plasma Cell Neoplasm	Biological: filgrastim;Biological: recombinant interferon alfa;Biological: sargramostim;Drug: busulf ...	Herbert Irving Comprehensive Cancer Center	National Cancer Institute (NCI)	Completed	18 Years	N/A	Both	75	Phase 2	United States
3	NCT00003353 (ClinicalTrials.gov)	July 1998	1/11/1999	High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Syst ...	A Phase II Study of High-Dose Melphalan With Hematopoietic Stem Cell Reconstitution for Patients Wit ...	Multiple Myeloma and Plasma Cell Neoplasm	Biological: filgrastim;Drug: melphalan;Procedure: bone marrow ablation with stem cell support;Proced ...	Eastern Cooperative Oncology Group	National Cancer Institute (NCI)	Completed	18 Years	70 Years	Both		Phase 2	United States

First Previous1Next Last